Galderma — full event log
Every event we have on file across every reporting year. The Data-by-year tab summarises the top 10 per year; this page shows them all.
← back to Data by year2024· 28 events
Galderma achieved 100% renewable electricity across all four manufacturing sites in 2023 (up from 57% in 2022) and maintained this in 2024. The company commits to maintaining 100% renewable electricity in its manufacturing plants as part of its Scope 1 & 2 carbon neutrality ambition by 2030.
sustainability_report p.31
Galderma debuted as a publicly-listed company (GALD) on the SIX Swiss Exchange on March 22, 2024 — the largest IPO in Switzerland since 2017 and one of the largest healthcare IPOs ever.
sustainability_report p.8
Galderma set target to achieve Scope 1 & 2 carbon neutrality across its four manufacturing plants by 2030. Includes phasing capex to replace carbon-intensive equipment and maintaining 100% renewable electricity.
sustainability_report p.31
Reduce water withdrawal intensity by 20% from a 2022 baseline and reduce waste intensity by 20% from a 2022 baseline across manufacturing plants by 2030.
sustainability_report p.67
In 2024, 50% of Galderma affiliates received Great Place to Work recognitions, including Galderma U.S. with workforce of ~1,200 people.
sustainability_report p.35
All four Galderma manufacturing plants obtained and maintain ISO 45001, ISO 14001 and OHSAS 18001 certifications.
sustainability_report p.31
Galderma is committed to enhancing water efficiency in manufacturing. Actions taken include reducing purge volumes and optimizing cooling processes. In 2024, water meters and sensors were installed across manufacturing plants and water withdrawal intensity decreased by more than 10% year-over-year. Target: 20% reduction by 2030 vs 2022 baseline.
sustainability_report p.135
In 2024, Galderma launched a Sustainable Packaging Initiative to identify all potential sustainable packaging solutions across the Dermatological Skincare portfolio, prioritising by impact/feasibility and considering resource availability such as post-consumer recycled (PCR) plastic. A multi-disciplinary project team across Operations, Procurement, R&D, Commercial and ESG was assembled.
sustainability_report p.137
Galderma achieved 100% renewable electricity across all four manufacturing sites in 2023 and maintained this in 2024. To achieve Scope 1 & 2 carbon neutrality in its manufacturing plants by 2030, Galderma developed site-specific plans that include phasing capital expenditure to replace carbon-intensive equipment (e.g., gas boilers) and maintaining 100% renewable electricity. The plan also comprises acquisition of high-quality carbon credits to compensate for residual emissions.
sustainability_report p.61
Galderma aims to reduce waste intensity by 20% from a 2022 baseline across its manufacturing plants by 2030.
sustainability_report p.135
L'Oréal acquired a 10% stake in Galderma post-IPO and joined in a complementary R&D collaboration.
sustainability_report p.10
To achieve Scope 1 & 2 carbon neutrality in manufacturing plants by 2030, Galderma's plan includes the acquisition of high-quality carbon credits to compensate for residual emissions, alongside replacing carbon-intensive equipment (e.g., gas boilers) and maintaining 100% renewable electricity. The company does not distinguish removals from offsets explicitly.
sustainability_report p.67
Galderma is phasing specific capital expenditure to replace carbon-intensive equipment such as gas boilers across its four manufacturing plants in Alby-sur-Chéran, Baie-D'Urfé, Hortolândia and Uppsala. Individual decarbonization plans are tailored to each site's specificity and maturity.
sustainability_report p.31
Galderma reduced water withdrawal intensity by more than 10% year-over-year in 2024 (5.0 m3/ton bulk vs 5.6 in 2023) and reduced waste intensity by more than 10% YoY. All manufacturing plants send zero waste to landfill. Target: 20% reduction in both water and waste intensity by 2030 vs 2022 baseline.
sustainability_report p.31
In 2024, Galderma launched a top supplier engagement program covering the top 80-90 suppliers in the most carbon-intensive procurement categories. Phase 1 focused on primary data collection including detailed life cycle assessments for specific raw materials to improve Scope 3 calculation accuracy. Phase 2 included discussions to identify mutually beneficial GHG reduction initiatives.
sustainability_report p.75
In 2024, Galderma launched a broad-based Sustainable Packaging Initiative to identify all potential sustainable packaging solutions across the Dermatological Skincare portfolio. It prioritizes initiatives by impact and feasibility and considers resource availability such as post-consumer recycled (PCR) plastic. A multi-disciplinary team includes Operations, Procurement, R&D, Commercial and ESG.
sustainability_report p.71
Galderma's Clean Beauty Charter lists ingredients to avoid/not use as part of every new Dermatological Skincare product development cycle. In 2024, the charter started including environmental assessment of ingredients (biodegradability, carbon footprint) to inform Scope 3 reduction efforts.
sustainability_report p.71
Galderma listed on SIX Swiss Exchange on March 22, 2024 - the largest IPO in Switzerland since 2017 and one of the largest healthcare IPOs ever.
sustainability_report p.14
Galderma aims to reduce water withdrawal intensity by 20% from a 2022 baseline across its manufacturing plants by 2030.
sustainability_report p.135
L'Oréal acquired a 10% stake in Galderma post-IPO and entered into a complementary R&D collaboration.
sustainability_report p.18
Site-specific decarbonisation plans include phasing capital expenditure to replace carbon-intensive equipment such as gas boilers in the four manufacturing plants (Alby-sur-Chéran, Baie-D'Urfé, Hortolândia, Uppsala) to achieve Scope 1 & 2 carbon neutrality by 2030.
sustainability_report p.135
In 2024, Galderma launched a top supplier engagement program involving its top 80-90 suppliers in the most carbon-intensive procurement categories. Phase 1 focused on primary data collection (detailed LCAs for raw materials) to improve Scope 3 accuracy; Phase 2 explored mutually beneficial reduction initiatives. The program targets development of detailed Scope 3 targets for key material categories in 2025.
sustainability_report p.145
Galderma committed to achieve Scope 1 & 2 carbon neutrality in its four manufacturing plants by 2030.
sustainability_report p.61
In 2024, 50% of Galderma's affiliates received Great Place to Work recognitions, including the U.S. affiliate.
sustainability_report p.69
Galderma aligned its ESG agenda with the Task Force on Climate-Related Financial Disclosures (TCFD) recommendations and conducted climate scenario analysis.
sustainability_report p.148
As part of its 2030 Scope 1 & 2 carbon neutrality plan, Galderma intends to acquire high-quality carbon credits to compensate for residual emissions that cannot be eliminated through equipment replacement and renewable electricity. The report does not specify durable removal technologies (DAC, BECCS, biochar).
sustainability_report p.135
All four manufacturing plants send zero waste to landfill. Initiatives in 2024 included introducing recyclable pallets in the Hortolândia plant and minimizing waste rejects from packaging lines in Baie-D'Urfé. Waste intensity decreased by more than 10% year-over-year. Target: 20% reduction by 2030 vs 2022 baseline.
sustainability_report p.135
Galderma's Clean Beauty Charter governs ingredients in new Dermatological Skincare product development. In 2024, the Charter was expanded to include environmental assessment of ingredients (biodegradability and carbon footprint) to inform Scope 3 reduction efforts.
sustainability_report p.137
2023· 4 events
Scope 3 emissions were first assessed in 2023 (332.1 ktCO2e). No assessment was performed for 2022.
sustainability_report p.67
Galderma achieved 100% renewable electricity across all four manufacturing sites in 2023, up from 57% in 2022.
sustainability_report p.67
Scope 3 emissions first assessed in 2023 (332.1 thousand tons CO2e). No assessment was performed in 2022.
sustainability_report p.135
All four Galderma manufacturing plants achieved 100% renewable electricity in 2023.
sustainability_report p.61